Hydrogen sulfide-mediated protein s-persulfidation: a regulatory mechanism in cardiovascular homeostasis Authors: Luzheng Zhang, Ziyi Gu, Song Xue, Yongyi Wang Published: 2026 ABSTRACT AbstractBackgroundCardiovascular diseases represent a primary cause of global mortality. Hydrogen sulfide operates as a major endogenous gasotransmitter that contributes to cardiovascular homeostasis through multiple biochemical mechanisms, among which protein S-persulfidation, represents a major redox-sensitive post-translational mechanism. This dynamically reversible modification converts cysteine sulfhydryl groups into highly nucleophilic persulfide groups to prevent irreversible oxidative damage.Aim of reviewThis review aims to systematically synthesize the current molecular understanding of S-persulfidation in cardiovascular biology. We evaluate the methodological evolution of site-specific detection technologies, delineate the regulatory mechanisms of sulfur signaling across distinct physiological axes, and assess the clinical translational potential of reactive sulfur species delivery systems.Key scientific concepts of reviewThe manuscript outlines the evolution of detection methodologies from early biotin-switch assays to Quantitative Thiol Reactivity Profiling. Mechanistically, S-persulfidation modulates membrane potential and vascular tone by altering the open probability of ion channels including KATP and Cav1.2. At the intracellular level, this modification regulates kinase cascades, redox sensors such as the Keap1/Nrf2 pathway, and metabolic enzymes to preserve mitochondrial bioenergetics. S-persulfidation also orchestrates genomic and post-transcriptional programs by directly modifying transcription factors and RNA-binding proteins. Furthermore, it reinforces the cellular protein quality control system to alleviate endoplasmic reticulum stress, optimize autophagy, and establish inhibitory checkpoints against apoptosis and pyroptosis. The review also evaluates systemic delivery vectors, including S-persulfidated albumin and engineered biomaterial scaffolds. Overcoming current translational barriers requires integrating spatial multi-omics with site-specific genetic validation to advance S-persulfidation biology toward precise cardiovascular therapeutics.Keywords: Hydrogen sulfide, S-sulfhydration, Cardiovascular diseases, Persulfidation, Post-translational modification Introduction Noncommunicable diseases remain a leading cause of morbidity and mortality worldwide, accounting for a significant portion of the global disease burden. Among these, cardiovascular diseases represent the largest and most clinically consequential category (Libby et al. 2019; WHO (N.d.)). Over the past three decades, the global prevalence of cardiovascular diseases has risen significantly, causing at least 19 million deaths annually (WHO (N.d.)). Current projections further suggest that the global burden of cardiovascular mortality will continue to increase substantially over the coming decades. (Chong et al. 2024) Hydrogen sulfide (H2S) is a colorless, flammable gas with high aqueous solubility (Meng et al. 2018). Historically, H2S was regarded as a toxic gas with harmful effects on the environment. However, this view has been fundamentally revised with the recognition of its endogenous signaling functions. H2S is now recognized as the third endogenous gas signaling molecule, following nitric oxide (NO) and carbon monoxide (Song et al. 2023). It is synthesized within mammalian cells and participates in multiple biological processes. At physiological pH, H₂S exists in acid–base equilibrium with its deprotonated form, hydrosulfide anion (HS⁻), with approximately one-third of total sulfide present as undissociated H₂S. This protonation state is biologically important because undissociated H₂S diffuses rapidly across lipid membranes, whereas HS⁻ exhibits higher nucleophilicity and contributes substantially to sulfide-dependent chemical reactivity (Cuevasanta et al. 2012). Unlike NO, which signals through the well-defined soluble guanylate cyclase–cyclic guanosine monophosphate axis, H2S does not operate through a single canonical receptor-effector pathway (Wobst et al. 2015). Instead, it exerts pleiotropic cardiovascular effects through multiple interconnected mechanisms, including modulation of mitochondrial respiration, antioxidant and anti-inflammatory signaling, ion-channel activity, thiol redox balance, and crosstalk with NO signaling (Szabo 2016; Wu et al. 2018). In the vascular system, H2S can enhance NO bioavailability, regulate endothelial NO synthase-dependent signaling, modulate downstream cyclic guanosine monophosphate metabolism, and influence vascular relaxation. (Bibli et al. 2017; Smimmo et al. 2024; Sun et al. 2017) Since Uy et al. systematically summarized and proposed the concept of post-translational modifications (PTMs) of proteins in 1977, PTMs have increasingly been recognized as one of the key pathways regulating cellular responses to stress stimuli (Uy and Wold 1977). Within the broad spectrum of PTMs, cysteine residue-mediated post-translational modifications are considered fundamental mechanisms for thiol-based redox regulation and signaling, acting on physiological processes such as cell proliferation, differentiation and migration (Guo et al. 2026). Common oxidative cysteine modifications include sulfenic acid (-SOH), S-glutathiolation(-SSG), disulfidation (-SSR), S-nitrosation(-SNO), and the more oxidized sulfinic (-SO₂H) and sulfonic acid (-SO₃H) states (Shi and Carroll 2019). Among these modifications, H₂S-mediated protein S-persulfidation exhibits unique chemical properties and biological effects. Historically, this modification was first described in the context of H₂S signaling as protein S-sulfhydration. In the seminal study by Mustafa et al., H₂S was shown to physiologically modify cysteine residues in a broad range of proteins, and this process was proposed as a post-translational modification (Mustafa et al. 2009). However, the term S-sulfhydration has gradually been reconsidered because it does not accurately reflect the underlying chemistry of the reaction as the modification does not involve hydration; rather, it denotes the conversion of a protein cysteine thiol group (-SH) into a protein persulfide group (-SSH) (Iciek et al. 2015). Accordingly, the term S-persulfidation has increasingly been adopted in sulfur redox biology to describe this reaction more precisely. In this review, we use S-persulfidation as the preferred biochemical term, while retaining S-sulfhydration only when referring to earlier literature. S-persulfidation is a highly precise and dynamically reversible biochemical process, centered on converting the relatively -SH group on protein cysteine residues into the highly nucleophilic and signal active -SSH group (Borisov and Forte 2021). Since both H₂S and its anion HS⁻ exist in low oxidation states alongside the reduced -SH group, direct thermodynamic reactions between them are thermodynamically unfavorable (Yang et al. 2015). Instead, persulfide formation generally depends on oxidized cysteine intermediates or reactive sulfur species. Two major pathways have been proposed. The first is a nucleophilic attack pathway, in which cysteine residues oxidized by reactive oxygen species or reactive nitrogen species to form R-SOH or R-SS-R. At this point, HS⁻, acting as a strong nucleophile, attacks these positively charged sulfur atoms (Xu et al. 2025). Through nucleophilic substitution reactions, it converts them into persulfides while releasing byproducts such as water molecules or sulfhydryl groups. The second is a sulfur-transfer pathway, in which reactive polysulfides (H2Sn) derived from H₂S can directly transfer an extra sulfur atom to a reduced R-SH group via a sulfur-sulfur exchange reaction. (Borisov and Forte 2021) Within cells, cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and the mitochondrial 3-mercaptopyruvate sulfurtransferase (3-MST) collectively form the sulfur signaling supply network (Jia et al. 2024). Recent evidence indicates that the H2S-producing enzyme itself is subject to S-persulfidation-based negative feedback. S-persulfidation of CSE at Cys137 suppresses its catalytic activity in vitro and is reversible upon thiol reduction, and vascular endothelial growth factor (VEGF)-triggered increases in endogenous H2S transiently elevate CSE S-persulfidation in human vascular smooth muscle cells (VSMCs). These findings support an autoregulatory loop that buffers sulfide bioavailability under fluctuating redox conditions (Fan et al. 2019).In hyperhomocysteinemia, CSE expression and activity are reduced, and CSE becomes functionally reprogrammed by reciprocal cysteine modifications: S-nitrosation suppresses, whereas H2S-driven persulfidation enhances, CSE binding and catalysis toward L-homocysteine. Mutation of Cys252/Cys255/Cys307/Cys310 abolishes both modifications and disrupts substrate binding, linking PTM control of CSE to homocysteine lowering and anti-atherogenic outcomes (Brasi-Velasco et al. 2025). 3-MST achieves efficient modification of substrate proteins by forming the 3-MST-SSH intermediate during its catalytic cycle. The resulting -SSH exhibits an α-effect due to the lone pair electrons of adjacent sulfur atoms, lowering its pKa by approximately 1–2 units compared to -SH. At physiological pH, this facilitates its dissociation into the negatively charged sulfur anion (R-SS-). This increased charge density and significantly enhanced nucleophilicity not only induces allosteric effects in proteins or boosts enzyme catalytic turnover rates but also functions as a “chemical shield” preventing cysteinyl residues from further oxidation into irreversible -SO₂H or -SO₃H groups. The reversibility of this process is meticulously maintained by the thioredoxin (Trx), glutaredoxin (Grx), peroxiredoxin (Prx) and sulfide quinone oxidoreductase system (Lang et al. 2025; Moseler et al. 2021; Couto et al. 2016; Mustafa et al. 2011). These systems reduce protein -SSH back to -SH, thereby limiting excessive -SSH accumulation and maintaining a dynamic redox signaling pathway. (Fig. 1). Molecular mechanisms of protein S-persulfidation and its enzymatic regulation. A Endogenous H2S and H2Sn are synthesized from L-Cysteine by CSE, CBS, and 3-MST. 3-MST operates primarily within the mitochondria and facilitates sulfur transfer via a 3-MST-SSH intermediate. B Protein S-persulfidation occurs through two primary chemical pathways: the nucleophilic attack of H2S on oxidized cysteine species or direct sulfur atom transfer from H2Sn to reduced R-SH. The modification is dynamically reversible, with the Trx system mediating the reduction of -SSH back to the original thiol state. C The conversion of a -SH to a -SSH results in a lower pKa and enhanced nucleophilicity due to the α-effect In regulating the physiological activities of the cardiovascular system, S-persulfidation involves multiple mechanisms. Studies indicate that S-persulfidation directly influences vascular tone and myocardial excitability by regulating the open probability of ion channels such as ATP-sensitive potassium channel (KATP), SERCA2a and L-type voltage-gated calcium channels (Cav1.2) (Mazza et al. 2013; Dai et al. 2019; Peng et al. 2023). In diabetic cardiomyopathy, H2S preserves Ca2+ cycling through a ‘PTM cross-talk’ mechanism (Meng et al. 2016). Additionally, recent research proposes that transcription factors including Sp1, Nrf2, and c-Jun can remodel cellular transcription profiles, thereby counteracting oxidative stress and inflammatory responses to maintain normal cardiovascular function (Zhang et al. 2023, 2024; Lin et al. 2018). The latest research further reveals that S-persulfidation regulates the protein quality control (PQC) system, the ubiquitin–proteasome system, and autophagy processes, while also participating in epigenetic remodeling, such as DNA methylation regulation. (Gotor et al. 2013; Cuevasanta et al. 2015) Despite these advances, several key issues remain unresolved. In the context of complex cardiovascular diseases, the dynamic regulation of S-persulfidation, the selectivity of modification sites, and the mechanisms by which S-persulfidation integrates with broader signaling networks are not yet fully understood. Therefore, this review provides a comprehensive overview and hierarchical analysis of the existing evidence. We first discuss the chemical basis and detection strategies that define S-persulfidation. Then, examining how this modification regulates cardiovascular effectors, including ion channels and calcium-handling proteins, before moving to intracellular signaling modules involving kinases, redox sensors, and metabolic enzymes. We further discuss how sulfur signaling reshapes transcriptional programs, epigenetic states, protein quality control, and programmed cell death. Finally, we extend this framework to regulation and translational delivery strategies. This organization is intended to clarify how site-specific cysteine modification is connected to cellular stress adaptation, vascular homeostasis, and therapeutic development. The evolution of s-persulfidation detection technology Accurately distinguishing protein S-persulfidation sites from free -SH and other oxidized sulfur residues, including -SOH, -SNO and disulfides, represents a core challenge in cardiovascular sulfur biology research. Due to the extreme reactivity of -SSH in biological fluids, current detection strategies primarily rely on chemical labeling with derivatization reagents. Early strategies and limitations Early detection of S-persulfidation largely relied on the modified biotin switch assay adapted from S-nitrosylation detection (Mustafa et al. 2009; Pan and Carroll 2013). This method employs methylmethanethiol sulfonate (MMTS) as a first-step blocking agent to immobilize free sulfhydryl groups, followed by labeling of S-sulfhydrate groups with biotin-HPDP. Subsequent chemical biology studies, however, confirmed that due to the stronger nucleophilicity of perthio groups compared to regular sulfhydryl groups, MMTS simultaneously blocks both -SH and -SSH groups in actual reactions (Filipovic et al. 2017). This compromises the specificity of the assay and can generate false-positive signals. Furthermore, incomplete MMTS capping can cause non-specific labeling during subsequent biotinylation steps (Cheung and Lau 2018). Consequently, this method is no longer recommended as a reliable approach for detecting perthio groups. Nevertheless, these early switch-based approaches played an important historical role by enabling the first exploratory vascular persulfidome studies. In atherosclerotic tissue, H2S increased global aortic S-persulfidation and a targeted MS workflow identified dozens of candidate persulfidated proteins, supporting a link between S-persulfidation, reduced lipid peroxidation, and enhanced antioxidant defense. (Gao et al. 2015) Subsequent enrichment-release strategies include the maleimide-based BTA method by Gao et al. and the iodoacetamide-based ProPerDP method by Dóka et al. (Dóka et al. 2016; Fan et al. 2020) In these approaches, biotin-labeled thiol-blocking reagents simultaneously block R-SH and R-SSH groups, forming sulfides with the former and mixed disulfides with the latter. Following amine-affinity enrichment of proteins or peptide chains, selective release of R-SSH-containing peptides occurs after treatment with reducing agents like dithioerythritol or phosphine triol. However, this method faces cross-interference from -SOH groups, and the reduction step itself is a significant source of false positives (Bibli et al. 2020).An important improvement was introduced by Bibli et al., who lysed cells and tissues in the presence of dimercaprol to trap R-SOH before labeling. This refinement reduced sulfenic-acid interference and enabled the identification of 1,536 differentially persulfidated cysteine residues in endothelial cells. (Zhang et al. 2013) Dimedone switch: dual selective conversion To address the low specificity issue in the aforementioned methods, Zhang et al. developed a novel thiol and S-sulfhydrate blocking reagent in 2014, termed methylsulfonylbenzothiazole-A (MSBT-A), which enables the formation of more specific mixed-aromatic disulfide bonds (Aroca et al. 2017; Wedmann et al. 2016). Additionally, they developed a biotin-linked cyanate ester (CN-biotin), which effectively reacts with S-sulfhydrate substrates while avoiding interactions with -SSG, -SOH, or -SNO substrates (Aroca et al. 2017). The presence of CN-biotin enables researchers to directly detect S-persulfidation in situ within tissues or assess S-persulfidation levels in cell lysates (Zivanovic et al. 2020). However, this strategy did not fully resolve interference from endogenous reactive disulfides, which remain functionally important in cells. To address this challenge, Zivanovic et al. proposed the dimedone-switch method (Aroca et al. 2021). The core of this approach lies in a two-step highly selective reaction: first, 4-chloro-7-nitrobenzofuran (NBF-Cl) is employed as a labeling reagent. The advantage of NBF-Cl lies in its ability to effectively block both -SH and -SSH groups while simultaneously blocking -SOH and amino groups. This process also generates green fluorescence, serving as a quantitative reference for protein loading. Second, a biotinylated dimedone probe, such as DCP-Bio1, is introduced. Due to the unique electrophilicity of NBF-labeled -SSH, this probe specifically replaces the NBF tag at this site while remaining inert toward NBF-blocked -SH or -SOH groups. Compared with earlier switch-based methods, this design substantially improves selectivity and generates highly stable labeled products. These can be directly enriched using streptavidin magnetic beads, followed by trypsin digestion and high-throughput proteomic analysis via LC–MS/MS (García-Calderón et al. 2023; Shen et al. 2025; Fu et al. 2019).(Fig. 2). Mechanism of Dimedone-Labeled S-persulfidatesin Proteomics Identification. A Labeling: -SH, -SSH, and -SOH are derivatized by NBF-Cl to form stable adducts. B Switching: DCP-Bio1 selectively displaces the NBF group only from-SSH, whereas NBF-blocked -SH and -SOH remain unreactive. C LC–MS/MS: Biotinylated proteins are enriched by streptavidin affinity purification, digested, and analyzed by LC–MS/MS to identify site-specific S-persulfidation events Quantitative thiol reactivity profiling: direct detection based on pKa With technological advancements, the Quantitative Thiol Reactivity Profiling (QTRP) method proposed by Fu et al. abandons the “blocking-then-conversion” logic of previous approaches, instead leveraging the physicochemical differences between -SSH and -SH groups (Yang et al. 2015). Its principle rests on the fact that -SH has a pKa of approximately 8.5, while -SSH exhibits a significantly reduced pKa of about 5.0–6.0 due to the electron density distribution characteristics of its sulfur atom. Accordingly, under mildly acidic conditions around pH 5.0, most free -SH become poorly nucleophilic, whereas -SSH remain reactive and can be selectively labeled. In this state, -SSH are first alkylated by the electrophilic alkyne-containing probe iodo-N-(prop-2-yn-1-yl)acetamide (IPM). The alkyne handle introduced by IPM then enables click chemistry with isotopically labeled UV-cleavable azido-biotin, followed by streptavidin enrichment and LC–MS/MS (Miljkovic et al. 2025). This workflow enables direct site-specific mapping while avoiding reductive release steps that may introduce artifacts caused by disulfide reduction. A major advantage of this approach is that site-specific persulfidation can be directly inferred by mass spectrometric detection of the + 32 Da sulfur-associated mass shift. Using this method, Fu et al. identified 1,547 S-persulfidation sites across multiple cell lines, distributed across 994 proteins (Yang et al. 2015). Recent research has further optimized the LC–MS/MS workflow by chemically trapping terminal sulfur atoms (Terminal S) and internal sulfur atoms (Internal S) within polysulfide chains and converting them into diagnostic signature products. This approach has achieved the first simultaneous sensitive quantification of H₂S, GSSG, and polysulfides. These advances not only improve site mapping, but also provide a broader view of intracellular sulfur-redox buffering in complex biological samples (Wei et al. 2025). Complementary to experimental proteomics, deep learning–based predictors have been developed to prioritize candidate S-persulfidation sites from primary sequences, enabling hypothesis generation and targeted validation when sample amounts or MS coverage are limiting (Moccia et al. 2026).(Fig. 3). Principles of QTRP for site-specific identification and multidimensional quantification of sulfur species. Under acidic conditions, free -SH are protonated and lose nucleophilic reactivity, whereas -SSH remain reactive because of their lower pKa. S-persulfidated residues are selectively labeled and linked to a UV-cleavable biotin tag through click chemistry, enabling peptide enrichment and release for LC–MS/MS analysis. This workflow also allows integrated quantification of H₂S, low-molecular-weight -SSH, and protein-bound H2Sn through selective trapping of terminal and internal sulfur atoms Regulation of ion channels and electrophysiological equilibrium by S-persulfidation Within the cardiovascular system, the spatial conformation and open probability of ion channels directly determine cellular membrane potential, excitability, and vascular tone (Grandi et al. 2016). S-persulfidation, acting as a precise molecular switch, enables real-time regulation of electrophysiological activity by altering the charge properties of key cysteine residues in channel proteins. Potassium channels: the core of vasotension and hyperpolarization Potassium channels represent one of the most widely distributed and functionally complex ion channel families in the cardiovascular system. Their primary physiological functions include maintaining the resting membrane potential, mediating vasodilation, and shaping action potentials in cardiomyocytes. (Lorigo et al. 2020; Hibino et al. 2010) KATP represent the primary target for H₂S-mediated vasoregulation through S-persulfidation. This channel comprises an octameric complex formed by the pore-forming subunit Kir6.1 and the regulatory subunit sulfonylurea receptor 2B (SUR2B) (McClenaghan and Nichols 2022; Ha et al. 2018). Studies demonstrate that H₂S directly s-sulfhydrates the Cys43 site on the Kir6.1 subunit (Mazza et al. 2013). This chemical transformation not only significantly reduces the channel's affinity for the inhibitor ATP but also substantially enhances its binding capacity to the activator phosphatidylinositol 4,5-bisphosphate. The modified KATP exhibits increased open probability, inducing substantial K⁺ efflux and hyperpolarization in VSMCs. This membrane potential change subsequently closes the voltage-gated calcium channel Cav1.2, reducing intracellular Ca2⁺ influx and ultimately causing vasodilation. Interestingly, the regulatory mechanism of S-persulfidation on Kir channels exhibits distinct functional differentiation. Ha et al. demonstrated that CSE-mediated endogenous sulfide signaling inhibits currents in multiple Kir2 and Kir3 subtypes by reducing channel sensitivity to PIP₂. (Kang et al. 2014) In addition to the pore-forming subunits, the regulatory subunit SUR2B is also a target of S-persulfidation. H₂S can modify the Cys24 and Cys1455 residues of SUR2B, not only contributing to the maintenance of channel complex activity but also exhibiting significant “modification antagonism.” For instance, the S-persulfidation of SUR2B effectively prevents pathological tyrosine nitration of its adjacent Kir6.1 subunit, thereby safeguarding the normal function of KATP under oxidative stress conditions. (Yang et al. 2018) According to Yang et al., S-persulfidation modifies the fast inactivation rates of both Kv1.4 and Kv3.4 channels (Liu et al. 2014). This effect arises from H₂S modifying Cys13 in the N-terminal ball domain of Kv1.4, as well as Cys6 and Cys24 in Kv3.4. Liu et al. demonstrated that S-persulfidation of the Kv4.3 channel also inhibits its repolarization, thereby maintaining muscle tension (Dallas et al. 2021). Since Kv4.3 is the primary subunit constituting the cardiac transient outward potassium current, whether this mechanism operates similarly in cardiovascular pathologies such as cardiac hypertrophy or heart failure warrants further investigation. Notably, S-persulfidation does not activate all potassium channels. In a study of hippocampal neurons, Dallas et al. demonstrated that S-persulfidation at the Cys73 site of the Kv2.1 protein inhibits channel activity, thereby increasing action potential firing frequency (Naik et al. 2016). However, whether this alteration contributes to arrhythmia onset or protection requires targeted validation within cardiovascular physiological contexts. Large-conductance calcium-activated potassium channels (BK represent another critical junction where S-persulfidation dictates vascular reactivity, often through intricate inter-channel crosstalk. Naik et al. identified a signaling cascade in the mesenteric endothelium where H2S does not initially target the BK directly, but rather induces S-persulfidation of TRPV4 (Yadav et al. 2023). This modification triggers a localized Ca2+ influx that subsequently activates endothelial BK channels, culminating in endothelial hyperpolarization and potent vasodilation. Yadav et al. demonstrated that S-sulfide modification also modulates BK in uterine arteries (Walewska et al. 2022). Beyond the cell membrane, Walewska et al. demonstrated that mitoBK undergoes S-persulfidation modification in the presence of hydrogen sulfide donors. This modification has minimal impact on the channel's basal activity but synergistically interacts with porphyrin iron ions to specifically restore channel function inhibited by heme. However, while these findings reveal a potential mechanism for cellular protection, their specific contribution to cardiovascular specificity requires further validation (Testai et al. 2023). Recent studies indicate that the hydrogen sulfide donor sinigrin promotes S-persulfidation modification of the Kv7.4 in cardiac mitochondria. This induces mild depolarization of the mitochondrial membrane potential and reduces calcium accumulation in the matrix, thereby protecting H9c2 cells and intact hearts from oxidative damage and ischemia/reperfusion (I/R) injury. (Yu et al. 2017) Ca2+ channels and Trp channels: regulation of calcium homeostasis Cav1.2 serve as the core pathway mediating excitation–contraction coupling in cardiomyocytes and regulating smooth muscle tension. In contrast to the positive regulation of KATP, Cav1.2 are one of the targets of H₂S-mediated negative feedback regulation. Research indicates that S-persulfidation-mediated modification suppresses Cav1.2 L-type Ca2⁺ currents (ICa, L) on VSMCs, thereby reducing Ca2⁺ influx. This modulates downstream PKC/ERK signaling pathways, ultimately inducing vascular smooth muscle relaxation (Peng et al. 2023). This regulatory action extends to the transient receptor potential (TRP) superfamily, which functions as a multimodal sensor for cardiovascular homeostasis. In the carotid sinus, Yu et al. propose that H₂S enhances baroreceptor sensitivity by promoting thiol modification and increased activity of TRPV1, a mechanism that contributes to systemic blood pressure regulation and resets the baroreflex (Peng et al. 2025). Furthermore, Naik et al. elucidated that S-persulfidation of TRPV4 on endothelial cells triggers localized Ca2⁺ sparks, subsequently activating BK to promote hyperpolarization-mediated vasodilation (Yadav et al. 2023). Beyond baroreflex tuning, H2S engages chemosensory reflex circuits relevant to hypertension. In chronic intermittent hypoxia models of obstructive sleep apnea, H2S activates the carotid body via Olfr78 and drives Adcy3-dependent cAMP production, which gates cyclic nucleotide-gated channels to amplify glomus-cell Ca2+ influx, sympathetic activity, and blood pressure elevation (Tang et al. 2026). Beyond membrane ion channels, intracellular Ca2+ cycling is also regulated by S-persulfidation. In diabetic cardiomyopathy, H₂S preserves Ca2+ cycling through a post-translational modification cross-talk mechanism. Specifically, S-persulfidation of the deSUMOylase SENP1 inhibits its deSUMOylase activity, thereby preserving the SUMOylated state of SERCA2a. Sustained SERCA2a SUMOylation restores SERCA2a activity, improves sarcoplasmic reticulum Ca2⁺ handling, and limits mitochondrial apoptosis (Meng et al. 2016). these mechanisms are summarized in Fig. 4. Mechanisms of S-persulfidation in regulating vascular tone and intracellular calcium homeostasis. A In VSMCs, S-persulfidation of the Kir6.1 subunit at Cys43 increases KATP open probability. The resulting K + efflux induces membrane hyperpolarization, which subsequently closes voltage-gated Cav1.2 channels to reduce Ca2+ influx and promote vasodilation. B In endothelial cells, S-persulfidation of TRPV4 channels triggers localized Ca2+ sparks. These sparks activate adjacent BK channels to induce endothelial hyperpolarization. C Beyond membrane ion channels, S-persulfidation regulates intracellular Ca2⁺ handling. H₂S-mediated S-persulfidation inhibits the deSUMOylase activity of SENP1, thereby preserving SERCA2a SUMOylation. This mechanism sustains SERCA2a activity and preserves Ca2+ cycling Collectively, these studies indicate that S-persulfidation regulates cardiovascular electrophysiology through a coordinated control of membrane hyperpolarization, Ca2+ entry, and sarcoplasmic reticulum Ca2+ recycling. Rather than uniformly activating or inhibiting ion channels, this modification tunes channel behavior according to channel subtype, cysteine-site accessibility, and cellular context, thereby linking sulfur redox chemistry to vascular tone, baroreflex sensitivity, and myocardial Ca2+ homeostasis. Regulation of kinases, receptors, and metabolic enzymes While ion-channel S-persulfidation explains rapid changes in membrane excitability and calcium handling requires sulfur-sensitive intracellular signaling networks. Kinases, receptors, redox sensors, and metabolic enzymes provide this second regulatory layer by converting local cysteine modification into broader changes in stress responses and cellular metabolism. Kinase cascades Protein kinase networks are major determinants of how cardiovascular cells respond to hemodynamic stress, oxidative injury, and metabolic challenge (Sen et al. 2020). As early as 2013, Mazza et al. proposed that the protein kinase B (Akt)/endothelial nitric oxide synthase (eNOS) pathway plays a crucial role in cardiac contractile and relaxation activities and is regulated by H2S-dependent signaling under physiological conditions (Dai et al. 2019). Unfortunately, subsequent research on this pathway in cardiovascular diseases has not been sufficiently explored. Outside the cardiovascular field, one study in Alzheimer’s disease reported that Akt persulfidation reduces its interaction with downstream GSK3β, suggesting that Akt may represent a broader persulfidation-sensitive signaling node. (Wu et al. 2018) A redox-sensitive H2S-NO interaction is mediated by proline-rich tyrosine kinase 2 (PYK2). Under oxidative stress, PYK2 activation increases inhibitory eNOS phosphorylation and H2S promotes PYK2 sulfhydration, suppresses PYK2 phosphorylation, relieves eNOS inhibition, and reduces infarct size. The absence of additive protection between PYK2 inhibition and H2S donation supports the existence of a shared signaling pathway (Bibli et al. 2017). Ca2+ -dependent protein kinase II (CaMKII) represents another kinase node targeted by S-persulfidation. H2S-elevating interventions promote CaMKII S-persulfidation, reduce CaMKII activity, preserve mitochondrial function, and limit lipid peroxidation during heart failure progression. (Zhao et al. 2014) MEK1 kinase is also a key target of sulfur signaling. H₂S-mediated S-persulfidation of MEK1 at the Cys341 site activates ERK1/2, promoting its phosphorylation, nuclear translocation, and interaction with poly ADP-ribose polymerase-1 (PARP-1). This process subsequently recruits XRCC1 and DNA ligase III to drive DNA repair pathways, thereby preventing vascular endothelial cell senescence. (Zhang et al. 2025) Receptors and second messenger S-persulfidation can directly reprogram receptor–ligand affinity. In pulmonary arterial smooth muscle cells, endogenous H2S persulfidates endothelin type A receptor (ETAR) at Cys69, thereby reducing ET-1/ETAR binding, suppressing proliferative signaling, and attenuating pulmonary vascular remodeling (Shuang et al. 2017). Similarly, H2S antagonizes insulin-like growth factor 1 (IGF-1) -driven VSMCs proliferation by downregulating IGF-1R expression and inducing IGF-1R S-persulfidation, thereby weakening IGF-1 binding. Furthermore, genetic or pharmacological blockade of IGF-1R signaling eliminates the anti-proliferative effect of H2S. (Andrés et al. 2025) In metabolic syndrome, impaired vasorelaxation converges on defective soluble guanylate cyclase (sGC)/cyclic guanosine monophosphate (cGMP) signaling. In db/db aortas, reduced CSE/CBS expression and diminished L-cysteine-evoked relaxation coincide with lower cGMP, while in vivo erucin restores cGMP and vasorelaxation without changing eNOS, implicating a smooth-muscle-centric mechanism involving enhanced sGC activity via S-persulfidation and concomitant phosphodiesterase 5 (PDE5) inhibition. (Smimmo et al. 2024) Consistent with this, H2S donors elevate cGMP levels and PKG activity while reducing PDE5A activity through S-persulfidation-dependent alterations in PDE5A dimerization. Furthermore, thiol reduction partially reverses these effects, supporting a direct redox-mediated control mechanism governing cGMP degradation (Sun et al. 2017). Fig. 5 summarizes how S-persulfidation integrates these mechanisms. S-persulfidation-mediated integration of kinase cascades, receptor signaling, and second messengers. A Kinase cascades are dynamically regulated by sulfur signaling. S-persulfidation of PYK2 suppresses its inhibitory phosphorylation of eNOS, thereby restoring NO production. Concurrently, targeted modification of CaMKII prevents mitochondrial injury, and MEK1 S-persulfidation activates the ERK pathway to drive DNA repair and prevent cellular senescence. B At the receptor level, S-persulfidation of ETAR at Cys69 and IGF-1R decreases their respective ligand binding affinities. This mechanism effectively inhibits abnormal vascular proliferation. C Within the second messenger network, S-persulfidation enhances sGC and PKG activity while simultaneously inhibiting PDE5A dimerization. This synergistic regulation sustains elevated cGMP levels to promote vasorelaxation Redox sensors In cardiovascular homeostasis, the Kelch-like ECH-associated protein 1 (Keap1)/nuclear factor erythroid 2–related factor 2 (Nrf2) is recognized as a core endogenous antioxidant mechanism. S-persulfidation modification, through precise remodeling of this pathway, not only functions in traditional anti-inflammatory and antioxidant contexts but also demonstrates significant protective effects in pathophysiological processes such as ferroptosis and cell therapy. In various oxidative stress models of the cardiovascular system, S-persulfidate modification primarily activates the transcription factor Nrf2 by targeting Keap1, thereby driving the expression of downstream protective genes (Lin et al. 2018; Wang et al. 2023; Hu et al. 2023; Xie et al. 2016; Su et al. 2025). Xie et al. demonstrated that in a diabetes-induced atherosclerosis model, H₂S induces Nrf2 dissociation from Keap1 and nuclear translocation by S-persulfidating Keap1 at Cys151 (Su et al. 2025). This process significantly reduces superoxide production and upregulates heme oxygenase-1 (HO-1) expression, thereby inhibiting foam cell formation and adhesion molecule production. Recent studies have revealed the central role of Keap1 S-persulfidation in inhibiting ferroptosis (Lin et al. 2018; Hu et al. 2023; Xie et al. 2016). In pulmonary arterial hypertension (PAH) therapy, H₂S supplementation activates Nrf2 via Keap1 S-persulfidation, effectively suppressing ferroptosis in human umbilical cord mesenchymal stem cells and thereby improving vascular remodeling (Xie et al. 2016). In a doxorubicin-induced cardiomyotoxicity model, H₂S-mediated Keap1 S-persulfidation further upregulates the SLC7A11/GSH/GPx4 antioxidant axis via Nrf2 activation, protecting cardiomyocytes from structural and functional damage caused by ferroptosis (Lin et al. 2018). Wang et al. further expanded the complexity of this axis in a diabetic cardiomyopathy model, demonstrating that H₂S not only directly modifies Keap1 but also S-sulfhydrates the E3 ubiquitin ligase Syvn1 at Cys115 (Hu et al. 2023). This modification enhances Syvn1-Keap1 interaction, promoting Keap1 ubiquitination and degradation. Through this dual mechanism of direct Keap1 modification and enhanced Keap1 degradation, H2S strengthens Nrf2-dependent defense against ferroptosis and mitochondrial apoptosis. Imbalance in sulfur signaling leads to failure of Keap1/Nrf2-mediated defense mechanisms. Restoring Keap1's S-persulfidation levels via slow-release donors (e.g., SG1002) or mitochondria-targeted sulfur carriers (e.g., AP39) represents a crucial therapeutic strategy for restoring cardiovascular homeostasis. Metabolic enzymes and mitochondrial homeostasis Mitochondrial bioenergetics and Fe–S/complex remodeling The efficiency of the mitochondrial respiratory chain directly determines the cell stress resistance. Recent study has revealed a bidirectional regulatory pattern of H2S on mitochondrial complexes I-V (Wang et al. 2024). Beyond tuning respiratory complex activity, S-persulfidation regulates Fe–S cluster biogenesis. In diabetic cardiomyopathy, reduced S-persulfidation of the cysteine desulfurase NFS1 compromises Fe–S cluster synthesis and is linked to mitochondrial dysfunction and PARthanatos. H2S supplementation restores NFS1 S-persulfidation at Cys383, improves mitochondrial function, and alleviates cardiac injury. (Drekolia et al. 2023) In aging, both CSE and 3-MST decline in cardiomyocytes, reducing S-persulfidation of complex I subunit NDUFB7 at Cys80/Cys90, increasing the NADH/NAD + ratio, and impairing complex I activity, thereby linking loss of S-persulfidation to age-associated metabolic inflexibility (Xiong et al. 2023). In type 1 diabetic cardiomyopathy, exogenous NaHS supplementation can enhance the activity of complexes I-III and V through S-persulfidation, while inhibiting the overactivation of complex IV, thereby maintaining mitochondrial functional stability. Reactive sulfur species beyond H2S also display disease-relevant signaling. A polysulfide donor (Na2S4) protects against diabetic cardiomyopathy through S-persulfidation of PPARγ and SIRT3, with pharmacologic inhibition and site-directed mutants abolishing benefit (Zhou et al. 2024). In parallel, cardiac ‘supersulfide’ metabolism shows divergent behavior in cardiomyocyte atrophy versus hypertrophy, and H2S accumulation alone does not phenocopy supersulfide depletion, supporting non-redundant roles of polysulfide pools in myocardial remodeling. (Kim and Hammerling 2020) Mitochondrial homeostasis under stress In addition to directly modifying respiratory chain components, sulfur signaling also optimizes respiratory function by intervening in the mitochondrial translocation of pathological proteins. In ischemic cerebral microvascular dysfunction, mitochondrial aggregation of p66Shc leads to respiratory defects and oxidative stress (Zhu et al. 2025). Zhu et al.'s research found that musk-containing Tongxin dripping pills, by increasing CSE/H2S levels, induce S-persulfidation of p66Shc to inhibit its expression and phosphorylation levels, block translocation to mitochondria, and ultimately salvage the respiratory function of microvascular endothelium. (Wu et al. 2022) H2S also stabilizes mitochondrial morphology by targeting the fission machinery. S-persulfidation of Drp1 at Cys607 suppresses its activation and mitochondrial translocation and competes with S-nitrosation at the same site, revealing a PTM crosstalk mechanism relevant to heart failure (Nishimura et al. 2019). Together, these findings indicate that mitochondrial integrity depends not only on respiratory complex regulation, but also on dynamic control of protein translocation and organelle morphology. (Pang et al. 2025) Metabolic rewiring and upstream modulators Pang et al. found that S-persulfidation of SIRT6 at the Cys141 site can block its entry into the cytoplasm to bind to enolase 3 (ENO3) (Yu et al. 2020). This intervention not only inhibited the deacetylation of ENO3 and its mediated glycolytic remodeling, but also effectively curbed the abnormal proliferation of VSMCs. In another study on DCM, Yu et al. elucidated the protective effect of H2S on the E3 ubiquitin ligase Hrd1 (Zhang et al. 2018). By S-persulfidating Cys115 of Hrd1, H2S enhanced its ubiquitination and degradation of vesicle-associated membrane protein 3, thereby blocking the translocation of fatty acid transporter CD36 to the plasma membrane and reducing pathological lipid accumulation in cardiomyocytes at its source. Gasotransmitter cross-talk further expands sulfur signaling logic. H2S can inhibit SO2 generation by persulfidating and inactivating aspartate aminotransferase (AAT1/2), whereas in H2S-deficient conditions, compensatory upregulation of SO2/AAT may partially buffer endothelial inflammatory activation (Sprenger et al. 2025).Lifestyle-linked metabolites can tune mitochondrial sulfide enzymes. Exercise increases mitochondrial ergothioneine, which binds to and activates MPST, enhancing mitochondrial respiration (Petrovic et al. 2025). Ergothioneine can also serve as an alternative substrate for CSE, boosting H2S and broad protein S-persulfidation and increasing NAD + via S-persulfidation-driven activation of cytosolic glycerol-3-phosphate dehydrogenase (Saha et al. 2015).(Fig. 6). The central role of S-persulfidation in maintaining mitochondrial homeostasis and directing metabolic rewiring. A S-persulfidation regulates mitochondrial bioenergetics by modulating respiratory complexes and preserving Fe-S cluster synthesis via the persulfurased NFS1. This maintains the NADH/NAD + ratio and overall respiratory efficiency. B Under stress conditions, S-persulfidation stabilizes mitochondrial morphology. The modification of Drp1 suppresses mitochondrial hyperfission, while the modification of p66Shc blocks its pathological translocation into the mitochondria. C Upstream metabolic inputs and cross-talk fundamentally rewire cellular metabolism. S-persulfidation of SIRT6 limits ENO3-driven glycolysis, and Hrd1 modification mitigates CD36-mediated pathological lipid accumulation. Furthermore, nutritional and lifestyle factors increase EGT availability. EGT acts upstream to activate MPST and CSE, thereby amplifying the protective mitochondrial sulfur signaling network Taken together, these findings position S-persulfidation as a signaling integrator that couples redox state to kinase activity, receptor responsiveness, antioxidant defense, and mitochondrial metabolism. Its cardiovascular effect is therefore not limited to a single pathway, but emerges from coordinated regulation of vascular relaxation, stress resistance, mitochondrial preservation, and metabolic adaptation. Transcriptional programs and epigenetic remodeling The effects of S-persulfidation on mitochondrial function and metabolic flux also provide a basis for longer-term gene-regulatory remodeling. Accordingly, sulfur signaling can influence cardiovascular disease progression not only by acute enzymatic regulation, but also by modifying transcription factors, chromatin-linked metabolic enzymes, and RNA-binding proteins. Allosteric regulation of transcription factors In the long-term remodeling and homeostasis maintenance of the cardiovascular system, S-persulfidation directly intervenes in the stability, nuclear translocation, and DNA binding activity of transcription factors, regulating gene expression. This regulation provides key molecular targets for addressing shear stress alterations, hyperglycemic stress, and ischemic injury. In the maintenance of vascular endothelial homeostasis, the transcription factor Sp1 exhibits a significant sulfur signal dependence. Saha et al. showed that decreased hydrogen sulfide levels due to CBS deficiency in endothelial cells weaken the S-persulfidation modification of Sp1 at Cys68 and Cys755 sites, thereby reducing its protein stability (Wittig et al. 2025). The absence of this modification impairs Sp1's transcriptional drive for VEGFR-2 and NRP-1, ultimately inducing endothelial dysfunction and impaired angiogenesis. Beyond disease settings, S-persulfidation also shapes endothelial differentiation programs relevant to vascular regeneration. Wittig et al. reported in an induced pluripotent stem cell differentiation model that S-persulfidation exerts a time-dependent and bidirectional effect: it preserves stemness by protecting OCT4 activity, while also enhancing ETS family activity and WNT signaling during mesodermal differentiation, thereby promoting endothelial specification and vascular organoid formation (Li et al. 2024). Furthermore, Li et al. revealed the mechanism of endothelial barrier damage in diabetic patients: H2S-mediated S-persulfidation of the E3 ubiquitin ligase TRAF7 at Cys327 weakens the interaction between TRAF7 and KLF4, thereby inhibiting KLF4 ubiquitination and degradation (Bibli et al. 2019).Stabilized KLF4 in turn enhances transcription of VE-cadherin and strengthens endothelial barrier integerity. S-persulfidation regulates atherosclerosis and plaque stability. At the shear stress sensing level, low shear stress downregulates endothelial CSE expression, leading to the loss of S-persulfidation at the Cys47 site on Prx6 and inducing lipid peroxidation (Zhou et al. 2023). Zhou et al. added that sulfur signaling can inhibit MEST-mediated endothelial-mesenchymal transition (EndMT) by S-sulfhydrating the transcription factor NFIL3, thereby delaying plaque progression (Chen et al. 2022). In VSMCs, S-persulfidation is key to maintaining the contractile phenotype and enhancing plaque stability. Chen et al. found that CSE/H2S promotes nuclear translocation and activates target genes such as ATG9A by S-persulfidating the Cys212 site of the autophagy core transcription factor TFEB, thereby reducing VSMCs apoptosis and increasing collagen secretion by enhancing autophagic flux (Huang et al. 2025). Furthermore, regarding lipid metabolism, Huang et al. proposed that S-persulfidation modification of the Cys241 site of HNF1α leads to structural reorganization and weakens its DNA binding affinity to PCSK9 (Tian et al. 2020). This mechanism effectively improves the lipid profile and alleviates atherosclerosis. In the pathological remodeling of myocardial hypertrophy and vascular calcification, S-persulfidation primarily functions by inhibiting the activity of specific transcription factors. Meng et al. elucidated that H2S-mediated S-persulfidation modification of the Cys664 site of Sp1 significantly weakens its transcriptional activity against the hypertrophic factor KLF5, thereby blocking KLF5's activation of downstream PDGF-A and atrial natriuretic peptide (ANP), effectively preventing myocardial hypertrophy (Zhang et al. 2024). At the level of vascular smooth muscle cell proliferation and calcification, FOXO1 and Stat3 are key targets. Tian et al. found that S-persulfidation of the Cys457 site of FOXO1 antagonizes its phosphorylation at Ser256, preventing FOXO1 efflux and thus inhibiting endothelin-1-induced abnormal proliferation of VSMCs (Zhu et al. 2022). Finally, regarding age-related medial degeneration and aneurysms, Zhu et al. found that S-persulfidated Sp1 can inhibit MMP2 transcription, synergistically inhibiting MMP activity and jointly maintaining the structural integrity of large blood vessels. (Lin et al. 2024) Arterial stiffness provides a clinically relevant ‘mechanical phenotype’ of vascular aging that is also regulated by S-persulfidation. In aging and AngII-driven models, VSMC H2S declines, while VSMCs-specific CSE deletion exacerbates stiffness and senescence. Mechanistically, H2S persulfidates Foxm1 at Cys210 to promote its nuclear translocation and transcriptional activity, restraining Gas1 signaling and attenuating VSMCs senescence and stiffness. (Zhang et al. 2021) Epigenetic sulfur signaling remodeling Besides directly regulating transcription factors, S-persulfidation also modulates cardiovascular homeostasis by reshaping the epigenetic landscape at the chromatin level. In diabetic vascular remodeling, H2S induces S-persulfidation of PDC-E1 at the Cys101 site, anchoring it in mitochondria and preventing its translocation to the nucleus, thereby limiting the supply of substrates for histone acetylation by nuclear acetyl-CoA and effectively inhibiting the abnormal proliferation of VSMCs (Luo et al. 2023). In another study, Luo et al. found that the ZEB2-HDAC1-NuRD complex in aortic dissection (AAD) reduces the S-persulfidation level of protein disulfide isomerase (PDI) at Cys343 and Cys400 by transcriptionally inhibiting CSE expression, thereby inducing severe endoplasmic reticulum stress and driving disease progression (Randhawa et al. 2022). Under myocardial ischemia stress, Ergothionein exhibits significant cytoprotective effects by maintaining the active histone marker H3K27ac and regulating the expression of the chromatin tissue protein HMGN1 (Liu et al. 2023). These studies collectively demonstrate that S-persulfidation modification, acting as a molecular bridge between metabolic flux and epigenetic programs, endows cardiovascular cells with epigenetic resilience against pathological damage by maintaining a dynamic balance in histone acetylation levels. NF-κB signaling modulation and post-transcriptional mRNA control In immune cells, H2S promotes SIRT1 expression and sulfhydration to suppress NF-κB p65 phosphorylation and cytokine expression in response to TMAO, and thiol reduction reverses this anti-inflammatory phenotype (Bibli et al. 2019). Beyond transcription factors, S-persulfidation also controls post-transcriptional mRNA stability. S-persulfidation of the RNA-binding protein HuR limits HuR dimerization and destabilizes inflammatory mRNAs such as CD62E. Inflammation-associated phosphorylation and inhibition of CSE diminishes HuR S-persulfidation, stabilizing HuR targets and accelerating endothelial activation and atherogenesis (Liu et al. 2024) (Table 1). Table 1S-persulfidation targets in transcriptional, epigenetic, and post-transcriptional regulationTargetCys SitesMechanismCardiovascular Relevant PhenotypeSp1 (Zhang et al. 2024; Wittig et al. 2025)Cys68, Cys755; Cys664Cys68/Cys755: stabilizes Sp1 → ↑VEGFR-2/NRP-1 transcription;Cys664: suppresses Sp1 pro-hypertrophic output → ↓KLF5 → PDGF-A/ANPEndothelial homeostasis; limits myocardial hypertrophyFoxm1 (Zhang et al. 2021)Cys210Promotes nuclear activity → restrains Gas1 signalingReduces VSMC senescence and stiffness; attenuates arterial agingTFEB (Huang et al. 2025)Cys212Enhances nuclear translocation → ↑ATG9A/autophagy programImproves VSMC survival and plaque stabilityHNF1α (Tian et al. 2020)Cys241Weakens DNA binding → ↓PCSK9 transcriptionImproves lipid profile; alleviates atherosclerosisFOXO1 (Zhu et al. 2022)Cys457Antagonizes Ser256 phosphorylation driven export → FOXO1 nuclear retentionSuppresses ET-1-driven abnormal VSMC proliferation associated remodelingKeap1 (Lin et al. 2018)Cys151Releases Nrf2 repression → ↑HO-1 and SLC7A11/GSH/GPx4 antioxidant axisAnti-ferroptosis protection in cardiometabolic injuryPDC-E1 (Luo et al. 2023)Cys101Retained in mitochondria → ↓nuclear acetyl-CoA supply → ↓histone acetylation driveSuppresses pathological VSMC proliferation in diabetic vascular remodelingPDI (Randhawa et al. 2022)Cys343, Cys400Preserves PDI folding capacity → ↓ERS/UPR burdenProtects against proteotoxic vascular injuryHuR (Liu et al. 2024)Cys13Limits HuR dimerization → ↓CD62E mRNA stabilityReduces endothelial activation and atherogenesisTRAF7 (Bibli et al. 2019)Cys327Reduces KLF4 ubiquitination → ↑KLF4 → ↑VE-cadherinPreserves diabetic endothelial injury S-persulfidation targets in transcriptional, epigenetic, and post-transcriptional regulation Cys68/Cys755: stabilizes Sp1 → ↑VEGFR-2/NRP-1 transcription; Cys664: suppresses Sp1 pro-hypertrophic output → ↓KLF5 → PDGF-A/ANP Protein quality control In parallel with transcriptional remodeling, cardiovascular system must preserve proteome integrity under oxidative, metabolic, and hemodynamic stress. S-persulfidation contributes to this adaptive layer by regulating endoplasmic reticulum (ER) folding, ubiquitin-dependent protein turnover, autophagy, and programmed cell death checkpoints. Proper protein delivery, targeting, folding, and regulation are essential for cellular health. Collectively, these processes constitute the PQC system. PQC integrity maintains the structural and functional homeostasis of cardiovascular cells. In the pathological processes of myocardial ischemia, myocardial hypertrophy, and DCM, the accumulation and misfolding of damaged proteins often induce cytotoxicity (Jyothidasan et al. 2024; Xu et al. 2011; Ren et al. 2021; Jiang et al. 2021).S-persulfidation exerts a broad protective effect across the PQC system by regulating ER stress-related chaperones, ubiquitin ligases, and autophagy machinery, thereby influencing protein folding, degradation, and stress adaptation. ER stress and sulfur modification homeostasis of chaperone proteins Disruption of ERhomeostasis triggers the unfolded protein response (UPR). S-persulfidation significantly alleviates proteotoxic stress in cardiovascular disease by enhancing the catalytic activity of key chaperone proteins. Protein disulfide isomerases (PDIs) are core folding enzymes mediating disulfide bond formation and rearrangement. In homocysteine-induced endothelial injury, Jiang et al. demonstrated that H2S can S-persulfidate the active site of PDIs, thereby enhancing their catalytic activity and alleviating ERS (Jiao et al. 2025). As previously mentioned, Luo et al. further clarified in their study of AAD that transcriptional repression of CSE by the ZEB2-HDAC1-NuRD complex in endothelial cells leads to a decrease in S-persulfidation levels at PDI Cys343 and Cys400, weakening their chaperone function, while restoring the sulfur-modified state of PDIs effectively inhibits the progression of AAD. (Randhawa et al. 2022) Furthermore, GRP78, a member of the heat shock protein family, is also an important target of sulfur signaling. Jiao et al. found that during VSMC aging, H2S S-persulfidates GRP78 at the Cys42, which significantly delays vascular wall structural degradation and aging by downregulating the three classic UPR pathways: IRE1, PERK, and ATF6 (Shinkai et al. 2017). Under cadmium exposure, Shinkai et al. indicated in their vascular endothelial study that reactive sulfur activates the HSF1 pathway by modifying HSP90, inducing the expression of downstream HSP70, demonstrating its compensatory protective role under environmental toxin challenges. (Sun et al. 2019) Ubiquitination and autophagy When chaperone proteins are unable to repair misfolded proteins, the cell activates the ubiquitin–proteasome system and autophagy to clear them. S-persulfidation exhibits substrate specificity in regulating these pathways, capable of either promoting or inhibiting protein degradation. In diabetic cardiomyopathy, the E3 ubiquitin ligase MuRF1 mediates the excessive degradation of contractile proteins and calcium transporters. Sun et al. and Peng et al. showed that H₂S-mediated S-persulfidation of MuRF1 at Cys44 inhibits MuRF1 E3 ligase activity, thereby protecting the myocardial structural proteins MHC6/MLC2, as well as SERCA2a, from ubiquitin-dependent degradation and preserving cardiac systolic and diastolic function. (Peng et al. 2022; Sun et al. 2021) Conversely, S-persulfidation modification often enhances the activity of ligases targeting pathological factors. In diabetic heart, H2S S-persulfidation of Cys115 of Hrd1 (SYVN1) enhances its ubiquitination and degradation of lipid synthesis proteins SREBP1, DGAT1/2, and Keap1 (Gotor et al. 2013; Hu et al. 2023; Sun et al. 2020). This targeted degradation reduces myocardial lipid accumulation but also indirectly activates the Nrf2 antioxidant program by degrading Keap1. In endothelial barrier maintenance, Li et al. pointed out that H2S modification of TRAF7 at Cys327 inhibits its degradation of the transcription factor KLF4, thereby protecting vascular integrity by enhancing VE-cadherin transcription. (Bibli et al. 2019) Sulfur signaling also plays a crucial role in the regulation of autophagy within the PQC system. Chen et al. demonstrated that S-persulfidation of the Cys212 on TFEB enhances its nuclear translocation, upregulates genes such as ATG9A, and stabilizes atherosclerotic plaques by increasing autophagy levels in VSMCs (Huang et al. 2025). Sun et al. found that H2S can S-persulfidate the deubiquitinase USP8, enhancing its activity and promoting its translocation to damaged mitochondria by reducing cytoplasmic Parkin ubiquitination levels, thereby initiating mitophagy (Jia et al. 2024). Furthermore, c-Jun S-persulfidation of Cys269 can also synergistically reduce oxidative stress by upregulating the autophagy adaptor protein p62. (Zhang et al. 2023) Programmed cell death checkpoints targeted by s-persulfidation S-persulfidation constrains inflammatory cell death programs. In macrophages, ox-LDL activates the NLRP3/caspase-1/GSDMD cascade, whereas H2S increases S-persulfidation of pro-caspase-1, reduces caspase-1 activity, and suppresses IL-1β/IL-18 release thereby inhibiting pyroptosis (Zhu et al. 2025). In endothelial cells, endogenous CSE/H2S limits LPS-induced pyroptosis via S-persulfidation-dependent activation of SIRT1, indicating a conserved anti-pyroptotic mechanism across cell types. (Diaz Sanchez et al. 2023) Caspase execution is also S-persulfidation sensitive. In TNF-α challenged endothelial cells, a slow-releasing H2S donor enhances pro-caspase-3 S-persulfidation, improves mitochondrial network integrity, and prevents cytochrome c–driven apoptosis (Ye et al. 2022). In doxorubicin cardiotoxicity, H2S persulfidates caspase-3 at Cys163, suppresses its activation and PARP cleavage, and thereby limits cardiomyocyte apoptosis. (Griffiths et al. 2023) Finally, S-persulfidation dynamics during myocardial I/R should be interpreted with attention to disease phase and detection methodology. Previous work showed that CysSSH administration at reperfusion reduces lipid peroxidation and improves post-ischemic cardiac function, supporting a protective role for S-persulfidation-based redox buffering (Wittig et al. 2023). However, recent LC–MS/MS-based simultaneous quantification of H2S, -SSH, and H2Sn showed that ischemic heart tissue accumulates H2S without a detectable increase in bulk protein or low-molecular-weight S-persulfidation (Wei et al. 2025). These findings suggest that H2S accumulation does not necessarily translate into global S-persulfidation expansion during ischemia, and that the protective effects of S-persulfidation donors may depend on reperfusion-associated redox conditions and local substrate availability. (Fig. 7). S-persulfidation regulates the PQC system across escalating stress thresholds. A Under initial stress, S-persulfidation maintains ER folding capacity. Modification of protein disulfide isomerase (PDI) enhances its chaperone activity, while modification of GRP78 downregulates the UPR to alleviate ER stress. B As stress intensity increases, the cell activates targeted clearance mechanisms. S-persulfidation exhibits substrate-specific regulation by inhibiting the E3 ligase MuRF1 to preserve structural proteins and activating Hrd1 to degrade pathological factors. Additionally, it enhances general autophagy via TFEB nuclear translocation and initiates mitophagy through USP8 activation. C At critical stress thresholds, S-persulfidation acts as a terminal checkpoint against programmed cell death. Direct modification of pro-caspase-1 inhibits GSDMD-mediated pyroptosis, while modification of caspase-3 at Cys163 suppresses apoptosis Overall, S-persulfidation reinforces PQC across escalating stress thresholds: it first preserves ER folding capacity, then adjusts ubiquitin- and autophagy-dependent clearance, and finally restrains pyroptotic and apoptotic execution. This layered organization explains why sulfur signaling can protect cardiovascular cells from proteotoxic stress without being restricted to a single ligase or death-effector protein. Thrombosis, immune regulation, and sex-dimorphic vascular responses Beyond cell-autonomous regulation of electrophysiology, metabolism, transcription, and PQC, S-persulfidation also extends sulfur signaling to multicellular cardiovascular processes, including thrombosis, endothelial activation, immune homeostasis, and sex-dependent vascular remodeling. These processes share a common biological feature: they depend on communication among endothelial cells, circulating proteins, immune cells, and VSMCs rather than on a single intracellular signaling module. At the vascular interface, endothelial tissue factor pathway inhibitors serve as direct anticoagulant targets for sulfhydryl signaling. H2S donors can maintain the interaction between tissue factor and factor Xa and protein S through S-persulfidation, thereby preventing excessive coagulation at the blood-vessel wall interface in endothelial cells (Grambow et al. 2020). This antithrombotic effect is further supported by the following evidence: the sustained-release donor GYY4137 reversibly inhibits endothelial cell activation markers and reduces vWF secretion without causing significant cytotoxicity, suggesting that sulfur signaling promotes a shift in endothelial cells toward an antithrombotic and anti-inflammatory phenotype (Barhoumi et al. 2011). The systemic relevance of S-persulfidation is further reflected in immune regulation. In Ang II-induced hypertension, CD4+ T-cell-specific deletion of CSE elevates basal blood pressure, aggravates hypertensive responses, reduces circulating and renal regulatory T cells, and increases perivascular T-cell infiltration. Mechanistically, constitutive S-persulfidation of LKB1 promotes AMP-activated protein kinase activation, thereby supporting regulatory T-cell differentiation and proliferation. The rescue of vascular relaxation and blood pressure control by adoptive transfer of regulatory T cells indicates that sulfur signaling contributes to blood pressure homeostasis through an immunometabolic mechanism rather than solely through direct vascular smooth muscle relaxation (Cui et al. 2020; Shuang et al. 2021). Sex-dependent vascular responses provide another example in which S-persulfidation integrates hormonal and proliferative signaling. In CSE-deficient VSMCs, estrogen promotes proliferation through formation of an IGF-1R α hybrid receptor complex. Endogenous or exogenous H2S induces S-persulfidation of IGF-1R, reduces hybrid receptor formation, and prevents estrogen-driven VSMCs proliferation (Xu et al. 2025). These findings suggest that impaired sulfur signaling may amplify hormone-sensitive vascular remodeling, whereas restoration of S-persulfidation can interrupt this proliferative axis. Collectively, these studies indicate that S-persulfidation functions as a systemic vascular regulatory mechanism linking coagulation restraint, endothelial quiescence, immune tolerance, and sex-dimorphic proliferative responses. Systemic and translational delivery of reactive sulfur species The systemic effects of sulfur signaling raise an important translational question: how can reactive sulfur chemistry be delivered in a manner that preserves biological specificity while avoiding nonspecific redox perturbation? Unlike single-target receptor agonists, H2S- or reactive sulfur species-based interventions depend on chemical speciation, release kinetics, tissue distribution, and the local redox environment. Therefore, the translational value of these strategies should be evaluated not only by the amount of sulfur delivered, but also by whether the delivered sulfur species match the biochemical requirements of the disease context. Circulating thiol reservoirs may provide one physiological mechanism for distributing sulfur equivalents across tissues. Albumin is the dominant circulating thiol carrier and can store S-persulfide equivalents as S-persulfidated albumin (-SSH-Alb). The levels of -SSH-Alb correlate with H2S availability and systemic redox tone, and this modified albumin can release H2S under reductive conditions. Functionally, -SSH-Alb attenuates inflammatory adhesion and inflammasome activation and protects against doxorubicin-induced cardiotoxicity with concomitant restoration of systemic redox balance. These findings suggest that circulating albumin is not merely a passive carrier, but may act as an inter-organ reservoir that transmits sulfur signaling under cardiometabolic stress (Pharoah et al. 2022). Pharmacological donor studies further indicate that reactive sulfur species are not interchangeable. In an ex vivo Langendorff I/R model, hydropersulfide donation showed stronger protection than H2S and dialkyl trisulfides in preserving post-ischemic function and limiting infarct size, suggesting that direct delivery of persulfide equivalents may better match the redox chemistry required during reperfusion in that experimental setting (Karwi et al. 2017). However, this observation should not be interpreted as categorical superiority of hydropersulfide donors in all contexts. Other studies have demonstrated substantial cardioprotection using H2S-releasing strategies, including slow-releasing and mitochondria-targeted donors (Miljkovic et al. 2022; Macabrey et al. 2022). Thus, the key translational issue is not whether one sulfur donor class is universally superior, but how donor chemistry, release profile, subcellular targeting, and disease phase determine therapeutic efficacy. Sulfur-based pharmacology has also been explored in vascular remodeling. Sodium thiosulfate, an approved sulfur source, limits intimal hyperplasia in murine restenosis models and human vein segments, including settings with CSE deficiency. Its effects are associated with increased intracellular polysulfide pools, enhanced global protein S-persulfidation, microtubule depolymerization, cell-cycle arrest, and reduced VSMCs migration and proliferation. This positions sodium thiosulfate as one example within a broader landscape of sulfur-based interventions rather than as an isolated therapeutic case (Nguyen et al. 2025). Controlled delivery systems may help overcome the major limitation of systemic sulfur donor administration, namely the difficulty of maintaining a localized and sustained sulfur signal within target cardiovascular tissues. Coaxial electrospun vascular grafts impregnated with stable H2Sn donors provide prolonged sulfide release, enhance endothelialization, promote macrophage polarization toward a reparative phenotype, and improve long-term graft integration and patency in vivo (Chen et al. 2025). Beyond vascular grafting, multifunctional iron-sulfide-based nanoformulations can release ferrous iron and H2Sn to suppress inflammation, promote angiogenesis, and accelerate tissue repair138. These material-based approaches indicate that the next translational stage of sulfur biology may depend on coupling defined reactive sulfur chemistry with spatially controlled delivery platforms. Taken together, systemic reservoirs, donor selection, drug repurposing, and biomaterial-enabled release should be viewed as interconnected strategies for converting S-persulfidation biology into precise cardiovascular therapeutics. Conclusions Limitations and challenges of current research on protein s-persulfidation Despite significant advances in elucidating the molecular mechanisms of protein S-persulfidation, several barriers must be addressed before H2S- and reactive sulfur species (RSS)-based strategies can be translated into cardiovascular therapeutics. A primary limitation lies in resolving the spatiotemporal dynamics of S-persulfidation across distinct cell types and subcellular compartments. Cardiovascular tissues are highly heterogeneous. While cutting-edge technologies, such as single-cell multi-omics and spatial transcriptomics, have revolutionized our understanding of cardiovascular subpopulations and tissue architecture, S-persulfidation detection methodologies have not yet integrated with these advanced platforms. Current chemoselective workflows, including QTRP and traditional LC–MS/MS, predominantly rely on bulk tissue lysates. This reliance inherently masks cell-specific redox responses and obscures dynamic compartmentalized sulfur fluxes between organelles. Bridging this technological gap to achieve spatially resolved or single-cell S-persulfidation profiling is critical for understanding how sulfur signaling orchestrates intercellular communication and microenvironmental adaptation during disease progression. Furthermore, the functional complexity of PTM crosstalk requires systematic resolution. S-persulfidation competes with or modulates other redox and regulatory PTMs, such as S-nitrosation and SUMOylation, potentially altering functional outputs depending on the cellular redox context. To elucidate these interactions, it is essential to use gene editing technologies and non-S-persulfidate mutants for site-specific validation, while employing experimental designs that directly measure target binding rather than relying solely on donor-induced phenotypic changes. Future research directions Future research must prioritize therapeutic precision. This entails defining the pharmacological non-equivalence of distinct reactive sulfur species and matching donor release kinetics to the specific therapeutic window of the disease. The development of tissue-targeted and sustained-release delivery platforms, such as coaxial electrospun vascular grafts and multifunctional nanoformulations, is necessary to overcome systemic dosing constraints and achieve localized signaling. Systemically, the identification of -SSH-Alb as a circulating reservoir indicates that S-persulfidation participates in inter-organ redox communication, necessitating further investigation in complex cardiometabolic models. Ultimately, integrating rigorous human-relevant validation with the rational development of precise delivery systems is essential for translating S-persulfidation biology into clinically actionable interventions for cardiovascular diseases. Acknowledgements The figures in this manuscript were prepared by Figdraw (https://www.figdraw.com). Abbreviations Aortic Dissection Atrial Natriuretic Peptide Large-conductance Calcium-activated Potassium Ca2+ -Dependent Protein Kinase II L-Type Voltage-Gated Calcium Channel 1.2 Cystathionine Β-Synthase Cyclic Guanosine Monophosphate Cystathionine Γ-Lyase Cysteine Cysteine Persulfide Diabetic Cardiomyopathy Dynamin-Related Protein 1 Dithiothreitol Endothelial Nitric Oxide Synthase Endothelial–Mesenchymal Transition Endoplasmic Reticulum Extracellular Signal-Regulated Kinase Endothelin-1 Endothelin Type A Receptor Iron–Sulfur Cluster Forkhead Box O1 Forkhead Box M1 Glutathione Glutathione Peroxidase 4 Hydrogen Peroxide Hydrogen Sulfide Hydrogen Polysulfides Heme Oxygenase-1 Human Antigen R Ischemia/Reperfusion Insulin-Like Growth Factor 1 Inhibitor Of ΚB Kinase Subunit Β ATP-Sensitive Potassium Channel Kelch-Like ECH-Associated Protein 1 KrÜPpel-Like Factor 4/5 Liquid Chromatography–Tandem Mass Spectrometry Liver Kinase B1 Lipopolysaccharide Mitogen-Activated Protein Kinase Kinase 1 Nuclear Factor Kappa B Nuclear Factor Erythroid 2–Related Factor 2 Neuropilin-1 Oxidized Low-Density Lipoprotein Pulmonary Arterial Hypertension Poly (ADP-Ribose) Polymerase Phosphodiesterase 5A Platelet-Derived Growth Factor A Protein Kinase C/G Protein Quality Control Post-Translational Modifications Proline-Rich Tyrosine Kinase 2 Quantitative Thiol Reactivity Profiling Soluble Guanylate Cyclase Sentrin-Specific Protease 1 Sarco/Endoplasmic Reticulum Ca2+-Atpase 2a Sirtuin 1/3/6 Solute Carrier Family 7 Member 11 Sulfur Dioxide Specificity Protein 1 Small Ubiquitin-Like Modifier Conjugation Sulfonylurea Receptor 2B Synoviolin 1 Transcription Factor EB Tissue Factor Pathway Inhibitor Transforming Growth Factor Beta 1 Trimethylamine N-Oxide Tumor Necrosis Factor Alpha TNF Receptor-Associated Factor 7 Thioredoxin Transient Receptor Potential Transient Receptor Potential Vanilloid 1/4 Ubiquitin-Specific Peptidase 8 Vascular Endothelial Cadherin Vascular Endothelial Growth Factor Vascular Smooth Muscle Cells Von Willebrand Factor Thiol Group Persulfide Group Authors’ contributions Conceptualization and writing, Z.L.Z., Investigation, S.X., Review and editing, S.X., Y.Y.W, Funding, Y.Y.W., Supervision and Visualization, Z.Y.G. All authors have read and agreed to the published version of the manuscript. Fundings This work was supported by the National Natural Science Foundation of China, grant numbers: 82271608, 81770339. Data availability No datasets were generated or analysed during the current study. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Song Xue, Email: xuesong@renji.com. Yongyi Wang, Email: wangyongyi@renji.com. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.